Best deals to access real time data! |
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
CHART Trader
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Cancer Genetics Inc | CGIX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.19 | -6.51% | 2.73 | 2.9499 | 2.6948 | 2.92 | 2.92 | 14:10:31 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 2.73 | 2.78 | 0.05 | 1.8% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 634 | 135,425 | $ 2.82 | $ 381,808 | 343,956 | 2.15 - 20.697 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 14:10:31 | 100 | $ 2.73 | USD |
Cancer Genetics Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 5.50M | 2.01M | $ -20.37M | -0.74 | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Cancer Genetics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CGIX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.07 | 3.18 | 2.6363 | 3.03 | 196,521 | -0.34 | -11.07% |
| 1 Month | 4.797 | 5.10 | 2.15 | 3.98 | 1,741,107 | -2.07 | -43.09% |
| 3 Months | 3.66 | 5.805 | 2.15 | 4.07 | 4,374,224 | -0.93 | -25.41% |
| 6 Months | 6.09 | 11.10 | 2.15 | 4.36 | 2,999,497 | -3.36 | -55.17% |
| 1 Year | 18.30 | 20.697 | 2.15 | 5.91 | 2,432,968 | -15.57 | -85.08% |
| 3 Years | 49.50 | 159.00 | 2.15 | 16.95 | 989,017 | -46.77 | -94.48% |
| 5 Years | 194.10 | 382.50 | 2.15 | 24.57 | 634,265 | -191.37 | -98.59% |
Cancer Genetics Description
| Cancer Genetics Inc is in the early stage of precision medicine, enabling individualized therapies in the field of oncology through diagnostic products and services and molecular markers. The company develops, commercializes and provides molecular- and biomarker-based tests and services that enable physicians to personalize the clinical management of each individual patient by providing genomic information to diagnose, monitor and inform cancer treatment. It also enables biotech and pharmaceutical companies to select candidate populations and reduce adverse drug reactions by providing information regarding genomic factors influencing subject responses to therapeutics. The company derives most of its revenue from the United States. |
